Xichun Yu Selected Research

Muscarinic M2 Receptor

1/2021	M2 muscarinic autoantibodies and thyroid hormone promote susceptibility to atrial fibrillation and sinus tachycardia in an autoimmune rabbit model.
1/2016	β1-Adrenergic and M2 Muscarinic Autoantibodies and Thyroid Hormone Facilitate Induction of Atrial Fibrillation in Male Rabbits.
6/2015	Activating autoantibodies to the β1/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism.
5/2011	Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.
9/2009	Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xichun Yu Research Topics

Disease

14	Tachycardia (Tachyarrhythmias) 02/2022 - 03/2008
6	Postural Orthostatic Tachycardia Syndrome 02/2022 - 07/2017
6	Sinus Tachycardia 01/2021 - 03/2013
6	Cardiac Arrhythmias (Arrythmia) 12/2015 - 11/2005
5	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2022 - 08/2020
5	Atrial Fibrillation 01/2021 - 09/2009
5	Myocardial Infarction 01/2010 - 02/2005
4	Graves Disease (Basedow Disease) 01/2021 - 08/2014
4	Hyperaldosteronism (Conn Syndrome) 10/2015 - 04/2002
4	Hypertension (High Blood Pressure) 04/2015 - 04/2002
4	Infarction (Infarctions) 03/2008 - 02/2005
3	Inflammation (Inflammations) 02/2022 - 04/2009
3	Obesity 01/2021 - 03/2007
3	Insulin Resistance 01/2021 - 03/2007
3	Hyperthyroidism 01/2016 - 09/2009
3	Hyperplasia 01/2015 - 04/2002
3	Adenoma (Adenomas) 01/2015 - 04/2002
3	Orthostatic Hypotension (Postural Hypotension) 10/2013 - 01/2012
3	Heart Diseases (Heart Disease) 05/2011 - 09/2008
3	Cardiomyopathies (Cardiomyopathy) 05/2011 - 09/2008
3	Ventricular Tachycardia 03/2008 - 02/2005
2	Vasovagal Syncope 01/2018 - 07/2017
2	Ischemia 03/2008 - 11/2005
1	Dizziness (Lightheadedness) 07/2017
1	Goiter 06/2015
1	Subacute Thyroiditis (Thyroiditis, De Quervain) 06/2015
1	Carcinoma (Carcinomatosis) 05/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2008
1	Myocarditis (Carditis) 09/2008
1	Persistent Infection 03/2007
1	Cushing Syndrome 03/2007
1	Infections 03/2007
1	Critical Illness (Critically Ill) 03/2007
1	Sepsis (Septicemia) 03/2007
1	Hyperglycemia 02/2007

Drug/Important Bio-Agent (IBA)

29	AutoantibodiesIBA 03/2022 - 09/2008
9	Adrenergic Agents (Adrenergic Drugs)IBA 12/2019 - 03/2009
6	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 03/2022 - 08/2020
6	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021 - 05/2011
5	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2022 - 07/2006
5	Muscarinic M2 ReceptorIBA 01/2021 - 09/2009
5	Peptides (Polypeptides)IBA 10/2019 - 09/2008
5	Immunoglobulin G (IgG)IBA 01/2018 - 09/2008
4	Cholinergic Agents (Cholinergics)IBA 02/2022 - 01/2016
4	LigandsIBA 02/2022 - 07/2017
4	AntibodiesIBA 01/2016 - 09/2008
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2010 - 11/2005
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 02/2022 - 03/2009
3	Thyroid HormonesIBA 01/2021 - 08/2014
3	ReninIBA 01/2018 - 04/2002
3	Type 1 Angiotensin ReceptorIBA 01/2018 - 05/2014
3	AldosteroneIBA 01/2015 - 04/2002
3	Proteasome InhibitorsIBA 04/2009 - 11/2005
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 03/2008 - 11/2005
2	Hormones (Hormone)IBA 03/2022 - 01/2021
2	EpitopesIBA 03/2022 - 09/2008
2	CytokinesIBA 02/2022 - 10/2021
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2014 - 07/2006
2	beta Adrenergic ReceptorsIBA 09/2008 - 02/2005
2	Bortezomib (Velcade)FDA Link 03/2008 - 11/2005
1	Muscarinic AntagonistsIBA 01/2022
1	Testosterone (Sustanon)FDA Link 10/2021
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2020
1	LipidsIBA 03/2020
1	Neutralizing AntibodiesIBA 10/2019
1	AngiotensinsIBA 01/2018
1	PeptidomimeticsIBA 12/2015
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 04/2015
1	ImmunosorbentsIBA 01/2015
1	EnzymesIBA 01/2015
1	Monoclonal AntibodiesIBA 10/2013
1	Insulin ReceptorIBA 09/2013
1	JNK Mitogen-Activated Protein KinasesIBA 09/2013
1	Glucose (Dextrose)FDA LinkGeneric 09/2013
1	Vasodilator Agents (Vasodilators)IBA 02/2012
1	Muscarinic M3 ReceptorIBA 02/2012
1	hydroxide ionIBA 01/2012
1	beta-1 Adrenergic Receptors (beta 1 Adrenergic Receptor)IBA 09/2009
1	Nadolol (Corgard)FDA LinkGeneric 09/2009
1	Atropine FDA LinkGeneric 09/2009
1	UbiquitinIBA 04/2009
1	Proteins (Proteins, Gene)FDA Link 04/2009
1	AutoantigensIBA 09/2008
1	Cardiac MyosinsIBA 09/2008
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 09/2008
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2007
1	GlucocorticoidsIBA 03/2007
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2007
1	NADH oxidaseIBA 02/2007

Therapy/Procedure

4	Ligation 03/2008 - 02/2005
1	Vagus Nerve Stimulation 02/2022
1	Injections 10/2019
1	Intravenous Infusions 02/2014
1	Gastrostomy 03/2007
1	Therapeutics 03/2007
1	Gastroplasty (Vertical-Banded Gastroplasty) 03/2007